These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7003604)

  • 21. Initial characterization of the major mouse cytochrome P450 enzymes involved in the reductive metabolism of the hypoxic cytotoxin 3-amino-1,2,4-benzotriazine-1,4-di-N-oxide (tirapazamine, SR 4233, WIN 59075).
    Riley RJ; Hemingway SA; Graham MA; Workman P
    Biochem Pharmacol; 1993 Mar; 45(5):1065-77. PubMed ID: 8461036
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of trans-stilbene oxide, phenobarbital and 3-methylcholanthrene as inducers of steroid metabolism by the rat liver microsomal cytochrome P-450 system.
    Meijer J; DePierre JW
    J Steroid Biochem; 1983 Apr; 18(4):425-35. PubMed ID: 6834827
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bioactivation of arachidonic acid by the cytochrome P450 monooxygenases of guinea pig lung: the orthologue of cytochrome P450 2B4 is solely responsible for formation of epoxyeicosatrienoic acids.
    Knickle LC; Bend JR
    Mol Pharmacol; 1994 Jun; 45(6):1273-80. PubMed ID: 8022420
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Catalytic activities of cytochrome P450 enzymes and UDP-glucuronosyltransferases involved in drug metabolism in rat everted sacs and intestinal microsomes.
    Takemoto K; Yamazaki H; Tanaka Y; Nakajima M; Yokoi T
    Xenobiotica; 2003 Jan; 33(1):43-55. PubMed ID: 12519693
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of prostaglandin E2 catabolism and potentiation of hepatic prostaglandin E2 action in rat hepatocytes by inhibitors of oxidative metabolism.
    Brass EP; Beyerinck RA; Garrity MJ
    Biochem Pharmacol; 1988 Apr; 37(7):1343-9. PubMed ID: 3162676
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Azoreduction of N,N-dimethyl-4-aminoazobenzene (DAB) by rat hepatic microsomes. Selective induction by clofibrate.
    Raza H; Levine WG
    Drug Metab Dispos; 1986; 14(1):19-24. PubMed ID: 2868860
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolism of valproic acid by hepatic microsomal cytochrome P-450.
    Prickett KS; Baillie TA
    Biochem Biophys Res Commun; 1984 Aug; 122(3):1166-73. PubMed ID: 6433908
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of substrates and inhibitors of cytochrome P-450 on the NADPH inhibition of the ATP-dependent, hepatic, microsomal calcium pump.
    Srivastava SP; Chen NQ; Holtzman JL
    FEBS Lett; 1990 Dec; 276(1-2):135-7. PubMed ID: 2148293
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Degradation of an alkaloid pheromone from the pale-brown chafer, Phyllopertha diversa (Coleoptera: Scarabaeidae), by an insect olfactory cytochrome P450.
    Wojtasek H; Leal WS
    FEBS Lett; 1999 Sep; 458(3):333-6. PubMed ID: 10570935
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The enzymatic formation of bilirubin.
    Schmid R; McDonagh AF
    Ann N Y Acad Sci; 1975 Apr; 244():533-52. PubMed ID: 1094885
    [No Abstract]   [Full Text] [Related]  

  • 31. Cooperativity of alpha-naphthoflavone in cytochrome P450 3A-dependent drug oxidation activities in hepatic and intestinal microsomes from mouse and human.
    Emoto C; Yamazaki H; Iketaki H; Yamasaki S; Satoh T; Shimizu R; Suzuki S; Shimada N; Nakajima M; Yokoi T
    Xenobiotica; 2001 May; 31(5):265-75. PubMed ID: 11491388
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Estrogen-2/4-hydroxylase activities in rat brain and liver microsomes exhibit different substrate preferences and sensitivities to inhibition.
    Theron CN; Russell VA; Taljaard JJ
    J Steroid Biochem; 1987 Nov; 28(5):533-41. PubMed ID: 3682818
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytochrome P-450-dependent oxidation of felodipine--a 1,4-dihydropyridine--to the corresponding pyridine.
    Bäärnhielm C; Skånberg I; Borg KO
    Xenobiotica; 1984 Sep; 14(9):719-26. PubMed ID: 6516445
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Species difference in the inhibition of drug metabolism by liver microsomes by different inhibitors.
    Kato R; Onoda K; Takayanagi M
    Jpn J Pharmacol; 1969 Sep; 19(3):438-50. PubMed ID: 4390624
    [No Abstract]   [Full Text] [Related]  

  • 35. Characterization of the activation of hepatic microsomal hydroxylation by betamethasone and alpha naphthoflavone.
    Benford DJ; Bridges JW
    Biochem Pharmacol; 1980 Sep; 29(17):2345-9. PubMed ID: 7426041
    [No Abstract]   [Full Text] [Related]  

  • 36. Cytochrome P-450 dependent metabolism of testosterone in rat skin.
    Mukhtar H; Athar M; Bickers DR
    Biochem Biophys Res Commun; 1987 Jun; 145(2):749-53. PubMed ID: 3593368
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modulation of aflatoxin B1 biotransformation in rabbit pulmonary and hepatic microsomes.
    Daniels JM; Massey TE
    Toxicology; 1992 Aug; 74(1):19-32. PubMed ID: 1514185
    [TBL] [Abstract][Full Text] [Related]  

  • 38. On the spectral intermediate at 440 nm formed during mixed function substrate oxidation.
    Illing HP; Kunke S; Netter KJ
    Biochem Pharmacol; 1974 Sep; 23(18):2603-16. PubMed ID: 4153422
    [No Abstract]   [Full Text] [Related]  

  • 39. Overview of enzyme systems involved in bio-reduction of drugs and in redox cycling.
    Kappus H
    Biochem Pharmacol; 1986 Jan; 35(1):1-6. PubMed ID: 2416318
    [No Abstract]   [Full Text] [Related]  

  • 40. Anaerobic dechlorination of trichlorofluoromethane by liver microsomal preparations in vitro.
    Wolf CR; King LJ; Parke DV
    Biochem Soc Trans; 1975; 3(1):175-7. PubMed ID: 1126531
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.